Preanalytical blood sample workup for cell‐free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics

In current molecular cancer diagnostics, using blood samples of cancer patients for the detection of genetic alterations in plasma (cell‐free) circulating tumor DNA (ctDNA) is an emerging practice. Since ctDNA levels in blood are low, highly sensitive Droplet Digital PCR (ddPCR) can be used for dete...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ginkel, Joost H., van den Broek, Daan A., van Kuik, Joyce, Linders, Dorothé, de Weger, Roel, Willems, Stefan M., Huibers, Manon M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633557/
https://www.ncbi.nlm.nih.gov/pubmed/28940814
http://dx.doi.org/10.1002/cam4.1184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633557/
https://www.ncbi.nlm.nih.gov/pubmed/28940814
http://dx.doi.org/10.1002/cam4.1184

Ejemplares similares